Talphera (TLPH) Accumulated Depreciation (2011 - 2022)
Talphera (TLPH) posted Accumulated Depreciation of $11.6 million for Q4 2022, up 0.77% on a QoQ basis from $11.5 million in Q3 2022, and up 7.48% year-over-year from $10.8 million in Q4 2021.
Analysis
Talphera (TLPH) Accumulated Depreciation (2011 - 2022) Analysis & Trends
Talphera has reported Accumulated Depreciation for 12 years, with the latest figure at $11.6 million in Q4 2022.
- On a quarterly basis, Accumulated Depreciation rose 7.48% year-over-year to $11.6 million in Q4 2022; TTM through Dec 2022 was $11.6 million, a 7.48% increase from a year earlier, with the FY2022 full-year figure at $11.6 million, up 7.48% from the prior year.
- Accumulated Depreciation was $11.6 million for Q4 2022 at Talphera, up from $11.5 million in the prior quarter.
- The five-year high for Accumulated Depreciation was $11.6 million in Q4 2022, with the low at $8.9 million in Q4 2018.
- Average Accumulated Depreciation over 5 years is $10.6 million, with a median of $10.8 million recorded in 2021.
- The sharpest annual moves came in 2020 and 2021: Accumulated Depreciation gained 10.86% in 2020, then gained 1.86% in 2021.
- Over 5 years, Accumulated Depreciation stood at $8.9 million in 2018, then increased by 6.8% to $9.6 million in 2019, then increased by 10.86% to $10.6 million in 2020, then rose by 1.86% to $10.8 million in 2021, then advanced by 7.48% to $11.6 million in 2022.
- The last three Accumulated Depreciation figures came in at $11.6 million (Q4 2022), $11.5 million (Q3 2022), and $11.3 million (Q2 2022), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | Talphera | 92.90 Mn | 92.90 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | 11.59 Mn |
| Sep 30, 2022 | 11.50 Mn |
| Jun 30, 2022 | 11.29 Mn |
| Dec 31, 2021 | 10.79 Mn |
| Dec 31, 2020 | 10.59 Mn |
| Dec 31, 2019 | 9.55 Mn |
| Dec 31, 2018 | 8.94 Mn |
| Dec 31, 2017 | 8.44 Mn |
| Dec 31, 2016 | 6.74 Mn |
| Dec 31, 2015 | 4.85 Mn |
| Dec 31, 2014 | 2.96 Mn |
| Dec 31, 2013 | 2.10 Mn |
| Dec 31, 2012 | 1.51 Mn |
| Dec 31, 2011 | 2.05 Mn |